Literature DB >> 20624038

Challenges of antibody-mediated protection against HIV-1.

George K Lewis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20624038      PMCID： PMC4104498          DOI： 10.1586/erv.10.70

Source DB:  PubMed          Journal:  Expert Rev Vaccines        ISSN： 1476-0584            Impact factor:   5.217


× No keyword cloud information.
  56 in total

1.  Duration of humoral immunity to common viral and vaccine antigens.

Authors:  Ian J Amanna; Nichole E Carlson; Mark K Slifka
Journal:  N Engl J Med       Date:  2007-11-08       Impact factor: 91.245

2.  Discordant memory B cell and circulating anti-Env antibody responses in HIV-1 infection.

Authors:  Yongjun Guan; Mohammad M Sajadi; Roberta Kamin-Lewis; Timothy R Fouts; Anthony Dimitrov; Zhixin Zhang; Robert R Redfield; Anthony L DeVico; Robert C Gallo; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-18       Impact factor: 11.205

Review 3.  Recent advances in the characterization of HIV-1 neutralization assays for standardized evaluation of the antibody response to infection and vaccination.

Authors:  Victoria R Polonis; Bruce K Brown; Andrew Rosa Borges; Susan Zolla-Pazner; Dimiter S Dimitrov; Mei-Yun Zhang; Susan W Barnett; Ruth M Ruprecht; Gabriella Scarlatti; Eva-Maria Fenyö; David C Montefiori; Francine E McCutchan; Nelson L Michael
Journal:  Virology       Date:  2008-03-25       Impact factor: 3.616

4.  Broad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals.

Authors:  Johannes F Scheid; Hugo Mouquet; Niklas Feldhahn; Michael S Seaman; Klara Velinzon; John Pietzsch; Rene G Ott; Robert M Anthony; Henry Zebroski; Arlene Hurley; Adhuna Phogat; Bimal Chakrabarti; Yuxing Li; Mark Connors; Florencia Pereyra; Bruce D Walker; Hedda Wardemann; David Ho; Richard T Wyatt; John R Mascola; Jeffrey V Ravetch; Michel C Nussenzweig
Journal:  Nature       Date:  2009-03-15       Impact factor: 49.962

5.  HIV-1 envelope induces memory B cell responses that correlate with plasma antibody levels after envelope gp120 protein vaccination or HIV-1 infection.

Authors:  Mattia Bonsignori; M Anthony Moody; Robert J Parks; T Matt Holl; Garnett Kelsoe; Charles B Hicks; Nathan Vandergrift; Georgia D Tomaras; Barton F Haynes
Journal:  J Immunol       Date:  2009-07-22       Impact factor: 5.422

6.  High-throughput isolation of immunoglobulin genes from single human B cells and expression as monoclonal antibodies.

Authors:  Hua-Xin Liao; Marc C Levesque; Ashleigh Nagel; Ashlyn Dixon; Ruijun Zhang; Emmanuel Walter; Robert Parks; John Whitesides; Dawn J Marshall; Kwan-Ki Hwang; Yi Yang; Xi Chen; Feng Gao; Supriya Munshaw; Thomas B Kepler; Thomas Denny; M Anthony Moody; Barton F Haynes
Journal:  J Virol Methods       Date:  2009-02-21       Impact factor: 2.014

7.  Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.

Authors:  Rachmat Hidajat; Peng Xiao; Qifeng Zhou; David Venzon; L Ebonita Summers; Vaniambadi S Kalyanaraman; David C Montefiori; Marjorie Robert-Guroff
Journal:  J Virol       Date:  2008-10-29       Impact factor: 5.103

Review 8.  The challenges of eliciting neutralizing antibodies to HIV-1 and to influenza virus.

Authors:  Gunilla B Karlsson Hedestam; Ron A M Fouchier; Sanjay Phogat; Dennis R Burton; Joseph Sodroski; Richard T Wyatt
Journal:  Nat Rev Microbiol       Date:  2008-02       Impact factor: 60.633

9.  Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.

Authors:  Ann J Hessell; Eva G Rakasz; Pascal Poignard; Lars Hangartner; Gary Landucci; Donald N Forthal; Wayne C Koff; David I Watkins; Dennis R Burton
Journal:  PLoS Pathog       Date:  2009-05-15       Impact factor: 6.823

10.  International network for comparison of HIV neutralization assays: the NeutNet report.

Authors:  Eva Maria Fenyö; Alan Heath; Stefania Dispinseri; Harvey Holmes; Paolo Lusso; Susan Zolla-Pazner; Helen Donners; Leo Heyndrickx; Jose Alcami; Vera Bongertz; Christian Jassoy; Mauro Malnati; David Montefiori; Christiane Moog; Lynn Morris; Saladin Osmanov; Victoria Polonis; Quentin Sattentau; Hanneke Schuitemaker; Ruengpung Sutthent; Terri Wrin; Gabriella Scarlatti
Journal:  PLoS One       Date:  2009-02-20       Impact factor: 3.240
View more
  9 in total

Review 1.  Role of Fc-mediated antibody function in protective immunity against HIV-1.

Authors:  George K Lewis
Journal:  Immunology       Date:  2014-05       Impact factor: 7.397

Review 2.  Env Exceptionalism: Why Are HIV-1 Env Glycoproteins Atypical Immunogens?

Authors:  P J Klasse; Gabriel Ozorowski; Rogier W Sanders; John P Moore
Journal:  Cell Host Microbe       Date:  2020-04-08       Impact factor: 21.023

3.  Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding.

Authors:  Yongjun Guan; Marzena Pazgier; Mohammad M Sajadi; Roberta Kamin-Lewis; Salma Al-Darmarki; Robin Flinko; Elena Lovo; Xueji Wu; James E Robinson; Michael S Seaman; Timothy R Fouts; Robert C Gallo; Anthony L DeVico; George K Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-13       Impact factor: 11.205

4.  Computer-guided binding mode identification and affinity improvement of an LRR protein binder without structure determination.

Authors:  Yoonjoo Choi; Sukyo Jeong; Jung-Min Choi; Christian Ndong; Karl E Griswold; Chris Bailey-Kellogg; Hak-Sung Kim
Journal:  PLoS Comput Biol       Date:  2020-08-31       Impact factor: 4.475

5.  B-cell depletion reveals a role for antibodies in the control of chronic HIV-1 infection.

Authors:  Kuan-Hsiang G Huang; David Bonsall; Aris Katzourakis; Emma C Thomson; Sarah J Fidler; Janice Main; David Muir; Jonathan N Weber; Alexander J Frater; Rodney E Phillips; Oliver G Pybus; Philip J R Goulder; Myra O McClure; Graham S Cooke; Paul Klenerman
Journal:  Nat Commun       Date:  2010-10-19       Impact factor: 14.919

Review 6.  Why Does the Molecular Structure of Broadly Neutralizing Monoclonal Antibodies Isolated from Individuals Infected with HIV-1 not Inform the Rational Design of an HIV-1 Vaccine?

Authors:  Marc H V Van Regenmortel
Journal:  AIMS Public Health       Date:  2015-05-06

7.  The impact of inflammation and immune activation on B cell differentiation during HIV-1 infection.

Authors:  Nicolas Ruffin; Pham Hong Thang; Bence Rethi; Anna Nilsson; Francesca Chiodi
Journal:  Front Immunol       Date:  2012-01-05       Impact factor: 7.561

8.  Targeting HIV-1 Env gp140 to LOX-1 Elicits Immune Responses in Rhesus Macaques.

Authors:  Gerard Zurawski; Sandra Zurawski; Anne-Laure Flamar; Laura Richert; Ralf Wagner; Georgia D Tomaras; David C Montefiori; Mario Roederer; Guido Ferrari; Christine Lacabaratz; Henri Bonnabau; Peter Klucar; Zhiqing Wang; Kathryn E Foulds; Shing-Fen Kao; Nicole L Yates; Celia LaBranche; Bertram L Jacobs; Karen Kibler; Benedikt Asbach; Alexander Kliche; Andres Salazar; Steve Reed; Steve Self; Raphael Gottardo; Lindsey Galmin; Deborah Weiss; Anthony Cristillo; Rodolphe Thiebaut; Giuseppe Pantaleo; Yves Levy
Journal:  PLoS One       Date:  2016-04-14       Impact factor: 3.240

9.  Computationally-driven identification of antibody epitopes.

Authors:  Casey K Hua; Albert T Gacerez; Charles L Sentman; Margaret E Ackerman; Yoonjoo Choi; Chris Bailey-Kellogg
Journal:  Elife       Date:  2017-12-04       Impact factor: 8.140
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.